Cargando…
Cardiac Adverse Events Related to Immune Checkpoint Inhibitors
[Figure: see text]
Autores principales: | Gujral, Dorothy M., Mouhayar, Elie N., Bhattacharyya, Sanjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298671/ https://www.ncbi.nlm.nih.gov/pubmed/34317204 http://dx.doi.org/10.1016/j.jaccas.2019.12.028 |
Ejemplares similares
-
Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
por: Chahine, Johnny, et al.
Publicado: (2020) -
Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
por: Norwood, Timothy G., et al.
Publicado: (2020) -
Left Ventricular Cavity Obliteration From Eosinophilic Myocarditis in a Patient With Classic Hodgkin Lymphoma
por: Brener, Michael I., et al.
Publicado: (2020) -
“Hot Septum” Sign of Constrictive Pericarditis
por: Argulian, Edgar, et al.
Publicado: (2020) -
Myocarditis in 2020: Advancements in Imaging and Clinical Management
por: Kafil, Tahir S., et al.
Publicado: (2020)